Alemtuzumab for relapsing-remitting multiple sclerosis. Diaz RA, Doss S, Burke MJ, George E, Adler AI Lancet Neurol. 2014 Sep; 13(9):869-70. PMID: 25285344. Abstract CommentRecommendBookmarkWatch